5/February/2022 Top Medical Bulletin - Video
Overview
Here are todays top medical stories
Ginger Supplementation may Relieve Persistent Symptoms in Hypothyroid patients with normal thyroid-stimulating hormone
Ginger and its benefits are being reported for a long time. Primary hypothyroidism is a common disease with a prevalence of 1-2%, with five to eight times greater prevalence among women. Some patients have persistent symptoms despite normal serum thyroid-stimulating hormone (TSH) levels. Recent studies have shown the protective effect of ginger against thyroid damage in animals and humans. To further examine, Dr Ali Tavakoli and his team conducted a study and evaluated the efficacy of ginger supplementation in relieving persistent symptoms among patients with hypothyroidism.
Preliminary results of a recent study suggest that ginger supplementation can help relieve persistent hypothyroid symptoms. The study published in the journal Evidence-Based Complementary and Alternative Medicine on January 20, 2022 reported the Food and Drug Administration (FDA) recognizes ginger as a safe dietary supplement.
For more information check out the full story on the link below:
Ginger Supplementation may Relieve Persistent Symptoms in Hypothyroid patients with normal TSH
Is estrogen protective against risk of brain shrinkage
An association between more estrogen exposure over the lifetime to greater brain volumes and fewer indicators of brain disease on brain scans in midlife. Reproductive history events signaling more estrogen exposure include longer reproductive span, pre-menopausal status, use of hormonal therapy (HT) and hormonal contraceptives (HC), and a higher number of children reveals a study published in Neurology, the medical journal of the American Academy of Neurology on November 3, 2021.
"We found that a number of ways a woman is exposed to estrogen—not having reached menopause, having more total reproductive years, having a higher number of children, using menopause hormone therapy or hormonal contraceptives—were associated with larger gray matter volumes in midlife," said author Lisa Mosconi, of Weill Cornell Medicine in New York, N.Y.
For more information check out the full story on the link below:
Is estrogen protective against risk of brain shrinkage?
Atrial shunt device might not reduce heart failure in patients
Surgical management has become crucial in heart failure, more than one-half of people with heart failure (HF) have a preserved left ventricular ejection fraction. Placement of an interatrial shunt device is said to reduce pulmonary capillary wedge pressure during exercise in patients with heart failure and preserved or mildly reduced ejection fraction.
Trial REDUCE LAP- HF-Il reported that placement of an atrial shunt device did not reduce the total rate of heart failure events or improve health status in the overall population of patients with heart failure and ejection fraction of greater than or equal to 40% published in The Lancet.
Intra Atrial shunt is inefficient in preventing heart failure
Stress factors to accelerate biological aging
Lack of stress management rises among the population despite efforts and medications in worser cases. In short bursts, stress can be positive, such as when it helps you avoid danger or meet a deadline. But a prolonged stress can be dangerous and have adverse effects on health.
Study published in the journal Translational psychiatry concluded that that cumulative stress is associated with epigenetic aging in a healthy population, and these associations are modified by bio behavioral resilience factors.
Chronic stress is linked to negative long-term health consequences, raising the possibility that stress is related to accelerated aging. Study reports cumulative stress was associated with accelerated Grim Age and stress-related physiologic measures of adrenal sensitivity (Cortisol/ACTH ratio) and insulin resistance (HOMA).
For more information check out the full story on the link below:
Speakers
